SABCS 2021 Conference Coverage on VuMedi

 

SABCS 2021 Conference Coverage on VuMedi
Avatar

Update on T-DXd vs. T-DM1 in HER2+ MBC: Subgroup Analyses From the Phase 3 DESTINY-Breast03 Study

By SABCS 2021 Conference Coverage on VuMedi FEATURING Sara A. Hurvitz
By SABCS 2021 Conference Coverage on VuMedi FEATURING Sara A. Hurvitz
904 views
December 22, 2021
This video was recorded prior to the FDA granting regular approval to Trastuzumab Deruxtecan in ...
read more ↘
Comments 0
Login to view comments. Click here to Login

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo
Videos
08:12

SABCS 2021 Evaluation of Tucatinib + (Paclitaxel + Pertuzumab + Tras…

SABCS 2021 Conference Coverage on VuMedi

D. Potter

197 views
18:03

Final Findings From the CONTROL Trial of Diarrheal Prophylaxis or Ne…

SABCS 2021 Conference Coverage on VuMedi

C. Barcenas

196 views
11:18

Oral SERD Elacestrant vs. Investigator’s Choice of Endocrine Monothe…

SABCS 2021 Conference Coverage on VuMedi

A. Bardia

298 views
13:40

Optimizing Use of HER2 Therapies in MBC

SABCS 2021 Conference Coverage on VuMedi

P. Sharma

194 views
08:21

Examination of Low HER2 Expression in Breast Cancer

SABCS 2021 Conference Coverage on VuMedi

A. Fernandez

132 views
05:44

SABCS 2021 on CNS Metastases as a Site of First Recurrence in Adjuva…

SABCS 2021 Conference Coverage on VuMedi

N. Lin

1.2K views
06:59

SABCS 2021 Update on the KEYNOTE-522 Trial of Neoadjuvant Pembro+Che…

SABCS 2021 Conference Coverage on VuMedi

P. Schmid

235 views
08:19

SABCS 2021 Interim Analysis of the PREDICT Registry: Changes in Trea…

SABCS 2021 Conference Coverage on VuMedi

P. Whitworth

272 views
04:20

SABCS 2021 on Sacituzumab Govitecan in mTNBC: Post-Progression Thera…

SABCS 2021 Conference Coverage on VuMedi

J. Cortes

239 views
10:39

SABCS 2021 KEYNOTE-355 Final Results: Efficacy of Pembro+Chemo vs. P…

SABCS 2021 Conference Coverage on VuMedi

J. Cortes

467 views
09:07

SABCS 2021 on MRI Screening vs. SYMptom-Directed Surveillance for Br…

SABCS 2021 Conference Coverage on VuMedi

K. Jerzak

397 views
07:02

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuz…

SABCS 2021 Conference Coverage on VuMedi

N. Lin

977 views
25:09

SABCS 2021 on Using the Appearance of a Resistance Mutation in Perip…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

479 views
32:47

SABCS 2021 Updated Results From the RxPONDER Trial in HR+/HER2- Brea…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

1.4K views
06:26

SABCS 2021 Update on the Clinical Utility of Genomic Profiling in MB…

SABCS 2021 Conference Coverage on VuMedi

F. Andre

338 views
11:25

SABCS 2021 PROs in ECOG-ACRIN EA1131: Platinum vs. Capecitabine in R…

SABCS 2021 Conference Coverage on VuMedi

K. Lisa Smith

278 views
14:35

SABCS 2021 Update on QoL Results From OlympiA Trial: Adjuvant Olapar…

SABCS 2021 Conference Coverage on VuMedi

P. Ganz

290 views
10:48

Update on T-DXd vs. T-DM1 in HER2+ MBC: Subgroup Analyses From the P…

SABCS 2021 Conference Coverage on VuMedi

S. Hurvitz

904 views
06:17

SABCS 2021: Does Chemotherapy Benefit Patients With HR+/HER2- ILBC?

SABCS 2021 Conference Coverage on VuMedi

M. Yaghi

1.5K views
07:16

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

SABCS 2021 Conference Coverage on VuMedi

A. Barrio

13 views
24:23

SABCS 2021 Updates on Refining Axillary Management After Neoadjuvant…

SABCS 2021 Conference Coverage on VuMedi

T. Mamounas

801 views
11:50

SABCS 2021 Update on Samuraciclib, a First-in-Class, Oral, Selective…

SABCS 2021 Conference Coverage on VuMedi

C. Coombes

333 views
13:08

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

SABCS 2021 Conference Coverage on VuMedi

K. Jhaveri

277 views
04:56

SABCS 2021 Update on Ipatasertib + Palbociclib and Fulvestrant in HR…

SABCS 2021 Conference Coverage on VuMedi

M. Oliveira

292 views
07:38

SABCS 2021 Update on T-DXd vs.T-DM1 in High-Risk HER2+ Residual Inva…

SABCS 2021 Conference Coverage on VuMedi

C. Geyer

503 views
04:45

SABCS 2021 Presentation on the Detection of ctDNA Post Neoadjuvant C…

SABCS 2021 Conference Coverage on VuMedi

M. Ignatiadis

401 views
24:21

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

SABCS 2021 Conference Coverage on VuMedi

A. Xu

505 views
05:24

SABCS 2021 Detection of Early Stage BC Recurrence Using a Personaliz…

SABCS 2021 Conference Coverage on VuMedi

W. Janni

227 views
06:06

SABCS 2021 MammaPrint and BluePrint Are Prognostic of Outcome Follow…

SABCS 2021 Conference Coverage on VuMedi

A. Chung

324 views
12:37

SABCS 2021 Update on Adjuvant Palbociclib in HR+/HER2- EBC: Final Re…

SABCS 2021 Conference Coverage on VuMedi

M. Gnant

546 views
08:18

SABCS 2021 Update on T-DXd in Patients With HER2+ or HER2-Low-Expres…

SABCS 2021 Conference Coverage on VuMedi

M. Vaz Batista

325 views
19:53

SABCS 2021 Update on IO and mTNBC: Which Chemo-Backbone and Biomarke…

SABCS 2021 Conference Coverage on VuMedi

R. Dent

445 views